Dyne Therapeutics Inc (DYN)
$25.73 -$0.41 (-1.60%) 4:37 PM 12/14/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$3.00B -
Day's Range
$25.08 - $26.57 -
Volume
827,677 -
52 Week Low / High
$10.33 - $47.45 -
PE Ratio
- -
PEG Ratio
0.19 -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 6
- Strong Buy
- 3
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $29.50
- Target Price
Company News
-
Dyne Therapeutics, Inc. - Presentations Will Feature Recent Clinical Data From DYNE-251 and DYNE-101 as Well as Preclinical Data in FSHD and Pompe Disease - WALTHAM, Mass., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company fo...
-
Dyne Therapeutics, Inc. (DYN): A Hot Stock to Buy Now — Oct 7th, 2024
We recently compiled a list of the 10 Best Hot Stocks To Buy Right Now.In this article, we are going to take a look at where Dyne Therapeutics, Inc. (NASDAQ:DYN) stands against the other hot stocks. While the market is seeing significant positives after the Fed rate cut, there have been s...
-
Dyne Therapeutics, Inc. - Presentations Will Feature Recent Clinical Data From DYNE-251 and DYNE-101 as Well as Preclinical Data in FSHD and Pompe Disease - WALTHAM, Mass., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company fo...
-
Dyne Therapeutics, Inc. (DYN): A Hot Stock to Buy Now — Oct 7th, 2024
We recently compiled a list of the 10 Best Hot Stocks To Buy Right Now.In this article, we are going to take a look at where Dyne Therapeutics, Inc. (NASDAQ:DYN) stands against the other hot stocks. While the market is seeing significant positives after the Fed rate cut, there have been s...
-
Dyne Therapeutics, Inc. - Presentations Will Feature Recent Clinical Data From DYNE-251 and DYNE-101 as Well as Preclinical Data in FSHD and Pompe Disease - WALTHAM, Mass., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company fo...
-
Dyne Therapeutics, Inc. (DYN): A Hot Stock to Buy Now — Oct 7th, 2024
We recently compiled a list of the 10 Best Hot Stocks To Buy Right Now.In this article, we are going to take a look at where Dyne Therapeutics, Inc. (NASDAQ:DYN) stands against the other hot stocks. While the market is seeing significant positives after the Fed rate cut, there have been s...
-
Dyne Therapeutics, Inc. (DYN): A Hot Stock to Buy Now — Oct 7th, 2024
We recently compiled a list of the 10 Best Hot Stocks To Buy Right Now.In this article, we are going to take a look at where Dyne Therapeutics, Inc. (NASDAQ:DYN) stands against the other hot stocks. While the market is seeing significant positives after the Fed rate cut, there have been s...
-
Dyne Therapeutics, Inc. - Presentations Will Feature Recent Clinical Data From DYNE-251 and DYNE-101 as Well as Preclinical Data in FSHD and Pompe Disease - WALTHAM, Mass., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company fo...
-
Dyne Therapeutics, Inc. (DYN): A Hot Stock to Buy Now — Oct 7th, 2024
We recently compiled a list of the 10 Best Hot Stocks To Buy Right Now.In this article, we are going to take a look at where Dyne Therapeutics, Inc. (NASDAQ:DYN) stands against the other hot stocks. While the market is seeing significant positives after the Fed rate cut, there have been s...
-
Dyne Therapeutics, Inc. (DYN): A Hot Stock to Buy Now — Oct 7th, 2024
We recently compiled a list of the 10 Best Hot Stocks To Buy Right Now.In this article, we are going to take a look at where Dyne Therapeutics, Inc. (NASDAQ:DYN) stands against the other hot stocks. While the market is seeing significant positives after the Fed rate cut, there have been s...
-
Dyne Therapeutics, Inc. (DYN): A Hot Stock to Buy Now — Oct 7th, 2024
We recently compiled a list of the 10 Best Hot Stocks To Buy Right Now.In this article, we are going to take a look at where Dyne Therapeutics, Inc. (NASDAQ:DYN) stands against the other hot stocks. While the market is seeing significant positives after the Fed rate cut, there have been s...
-
Dyne Therapeutics, Inc. (DYN): A Hot Stock to Buy Now — Oct 7th, 2024
We recently compiled a list of the 10 Best Hot Stocks To Buy Right Now.In this article, we are going to take a look at where Dyne Therapeutics, Inc. (NASDAQ:DYN) stands against the other hot stocks. While the market is seeing significant positives after the Fed rate cut, there have been s...
-
Dyne Therapeutics, Inc. - Presentations Will Feature Recent Clinical Data From DYNE-251 and DYNE-101 as Well as Preclinical Data in FSHD and Pompe Disease - WALTHAM, Mass., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company fo...
-
Dyne Therapeutics, Inc. - Presentations Will Feature Recent Clinical Data From DYNE-251 and DYNE-101 as Well as Preclinical Data in FSHD and Pompe Disease - WALTHAM, Mass., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company fo...
-
Dyne Therapeutics, Inc. - Presentations Will Feature Recent Clinical Data From DYNE-251 and DYNE-101 as Well as Preclinical Data in FSHD and Pompe Disease - WALTHAM, Mass., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company fo...
-
Dyne Therapeutics, Inc. - Presentations Will Feature Recent Clinical Data From DYNE-251 and DYNE-101 as Well as Preclinical Data in FSHD and Pompe Disease - WALTHAM, Mass., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company fo...
-
Dyne Therapeutics, Inc. (DYN): A Hot Stock to Buy Now — Oct 7th, 2024
We recently compiled a list of the 10 Best Hot Stocks To Buy Right Now.In this article, we are going to take a look at where Dyne Therapeutics, Inc. (NASDAQ:DYN) stands against the other hot stocks. While the market is seeing significant positives after the Fed rate cut, there have been s...
Similar Stocks
Portfolio
Comprised of 1 portfolios